Proto Labs (PRLB) Cash & Equivalents (2011 - 2026)

Proto Labs has disclosed Cash & Equivalents across 16 years of filings, most recently posting $127.9 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 41.53% year-over-year to $127.9 million; the TTM figure through Jun 2026 stood at $127.9 million (up 41.53% YoY), while the FY2025 annual figure was $110.8 million, up 24.42% from the prior year.
• Cash & Equivalents came in at $127.9 million for Q2 2026 at Proto Labs, up from $124.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $127.9 million in Q2 2026 to a low of $54.7 million in Q2 2022.
• Average Cash & Equivalents over 5 years is $85.0 million, with a median of $85.8 million recorded in 2023.
• Year-over-year, Cash & Equivalents declined 14.21% in 2022 and jumped 49.92% in 2026.
• Over 5 years, Cash & Equivalents stood at $56.6 million in 2022, then jumped by 48.15% to $83.8 million in 2023, then grew by 6.3% to $89.1 million in 2024, then gained by 24.42% to $110.8 million in 2025, then climbed by 15.42% to $127.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $127.9 million in Q2 2026, $124.0 million in Q1 2026, and $110.8 million in Q4 2025.